Nurix Therapeutics, Inc. (NRIX)

CIK 1549595 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Nurix Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 2026SCHEDULE 13G/A0000315066-26-002803
Nov 4, 202640001817217-26-000016
Nov 4, 20261440001950047-26-010683
Nov 4, 202640001817199-26-000036
Nov 3, 20261440001950047-26-010618
Nov 3, 20268-K0001549595-26-000055
Nov 2, 202640001817199-26-000034
Nov 2, 20261440001950047-26-010564
Nov 2, 202640001817160-26-000023
Nov 2, 202640001817217-26-000014
Oct 15, 202640001817160-26-000021
Oct 14, 20261440001950047-26-010217
Oct 14, 202640001226675-26-000006
Oct 13, 202610-Q0001549595-26-000049
Oct 13, 20268-K0001549595-26-000048
Oct 2, 20261440001950047-26-010001
Oct 2, 202640001817199-26-000032
Sep 23, 2026SCHEDULE 13G0001193125-26-399480
Sep 2, 20261440001950047-26-009016
Sep 2, 202640001817199-26-000030
Sep 1, 202640001817160-26-000019
Aug 14, 2026SCHEDULE 13G0001104659-26-097100
Aug 14, 2026SCHEDULE 13G/A0000902664-26-003499
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097194
Aug 14, 2026SCHEDULE 13G0000080255-26-000570